KAZIA THERAPEUTICS LTD (KZIA) Form 10-Q Quarterly Reports
KAZIA THERAPEUTICS LTD (KZIA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: KZIA
CIK: 1075880
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 06/30
State: C3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO Audit Pty Ltd
Auditor SinceSince 6/30/2023 12:00:00 AM
Lead Engagement PartnerGareth Few
Audit LocationSydney, Australia
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-02 | — | SCHEDULE 13G/A Filing | 0002044285-26-000010 | View SEC Doc Filr Page |
| 424B3 | 2026-09-22 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-101975 | View SEC Doc Filr Page |
| 424B3 | 2026-09-22 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-101974 | View SEC Doc Filr Page |
| 424B3 | 2026-09-22 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-101972 | View SEC Doc Filr Page |
| 424B3 | 2026-09-22 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-101971 | View SEC Doc Filr Page |
| 6-K | 2026-09-22 | 2026-09-22 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-101967 | View SEC Doc Filr Page |
| 424B3 | 2026-09-18 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-101404 | View SEC Doc Filr Page |
| 424B3 | 2026-09-18 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-101403 | View SEC Doc Filr Page |
| 424B3 | 2026-09-18 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-101402 | View SEC Doc Filr Page |
| 424B3 | 2026-09-18 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-101401 | View SEC Doc Filr Page |
| 6-K | 2026-09-18 | 2026-09-18 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-101400 | View SEC Doc Filr Page |
| 424B3 | 2026-09-01 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-096268 | View SEC Doc Filr Page |
| 424B3 | 2026-09-01 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-096267 | View SEC Doc Filr Page |
| 424B3 | 2026-09-01 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-096266 | View SEC Doc Filr Page |
| 424B3 | 2026-09-01 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-096265 | View SEC Doc Filr Page |
| 6-K | 2026-09-01 | 2026-09-01 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-096263 | View SEC Doc Filr Page |
| 424B3 | 2026-08-31 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-095355 | View SEC Doc Filr Page |
| 424B3 | 2026-08-31 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-095353 | View SEC Doc Filr Page |
| 424B3 | 2026-08-31 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-095351 | View SEC Doc Filr Page |
| 424B3 | 2026-08-31 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-095349 | View SEC Doc Filr Page |
| 6-K | 2026-08-31 | 2026-08-31 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-095348 | View SEC Doc Filr Page |
| 6-K | 2026-08-31 | 2026-08-31 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-095310 | View SEC Doc Filr Page |
| 424B5 | 2026-08-31 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-095303 | View SEC Doc Filr Page |
| 6-K | 2026-08-28 | 2026-08-28 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-094603 | View SEC Doc Filr Page |
| 424B5 | 2026-08-28 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-094600 | View SEC Doc Filr Page |